Maria Taboada
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Prostate Cancer Treatment and Research 3
- Occupational and environmental lung diseases 3
- Lung Cancer Treatments and Mutations 2
- Oncology 8
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 2
- PARP inhibition in cancer therapy 1
- Co-authors
- Scott Antonia (5 shared papers)Paul K. Stockman (3 shared papers)Arnaud Scherpereel (2 shared papers)Anne S. Tsao (2 shared papers)Luana Calabrò (2 shared papers)Alessandra Bearz (2 shared papers)Michele Maio (2 shared papers)Dariusz M. Kowalski (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Annals of Oncology (3 papers)The Prostate (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)Clinical and Translational Science (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Maria Taboada
16 papers receiving 880 citations
Maria Taboada's Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 444
- Pulmonary and Respiratory Medicine 431
- Immunology 88
- Biotechnology 36
- Otorhinolaryngology 12
Countries citing papers authored by Maria Taboada
This map shows the geographic impact of Maria Taboada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Taboada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Taboada more than expected).
Fields of papers citing papers by Maria Taboada
This network shows the impact of papers produced by Maria Taboada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Taboada. The network helps show where Maria Taboada may publish in the future.
Co-authors
The 25 scholars most cited alongside Maria Taboada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial Hit paper breakdown → | 2017 | 323 |
| 2 | Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC Hit paper breakdown → | 2019 | 315 |
| 3 | 2013 | 51 | |
| 4 | 2016 | 35 | |
| 5 | 2011 | 30 | |
| 6 | 2019 | 28 | |
| 7 | 2022 | 26 | |
| 8 | 2015 | 21 | |
| 9 | 2019 | 18 | |
| 10 | 2011 | 16 | |
| 11 | 2019 | 12 | |
| 12 | 2010 | 10 | |
| 13 | 2010 | 9 | |
| 14 | 2009 | 2 | |
| 15 | 2009 | 2 | |
| 16 | 2019 | 1 |
About Maria Taboada
Maria Taboada is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Occupational Therapy and Epidemiology, having authored 16 papers that have together received 899 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Prostate Cancer Treatment and Research (3 papers), Occupational and environmental lung diseases (3 papers), Lung Cancer Treatments and Mutations (2 papers), Esophageal Cancer Research and Treatment (2 papers), Colorectal Cancer Treatments and Studies (2 papers), PARP inhibition in cancer therapy (1 paper) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Oncology (444 citations), Pulmonary and Respiratory Medicine (431 citations), Immunology (88 citations), Biotechnology (36 citations) and Otorhinolaryngology (12 citations). Maria Taboada has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Scott Antonia, Paul K. Stockman, Arnaud Scherpereel, Anne S. Tsao, Luana Calabrò, Alessandra Bearz, Michele Maio, Dariusz M. Kowalski, Kristiaan Nackaerts and Federica Grosso. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Prostate, Journal of Antimicrobial Chemotherapy and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.